COMPANY

Fulcrum Therapeutics

Fulcrum Therapeutics is developing small molecules for genetically defined diseases. From company website Source · Oct 12, 2026

Keywords: small molecules

Profile checked Oct 10, 2026

Timeline

Dec 10, 2025 Raise Follow-on offering: $175M (total, as published), announced Dec 10, 2025. Source: SEC filing. source ↗

Raised: $175.0M. Last 2 years.

Dec 10, 2025 Follow-on offering: $175M (total, as published), announced Dec 10, 2025. Source: SEC filing. source ↗